Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1966 Jan 15;1(5480):119–120.

Methyldopa in hypertension.

PMCID: PMC1843320  PMID: 5901568

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAYLISS R. I., HARVEY-SMITH E. A. Methyldopa in the treatment of hypertension. Lancet. 1962 Apr 14;1(7233):763–768. doi: 10.1016/s0140-6736(62)91782-8. [DOI] [PubMed] [Google Scholar]
  2. CANNON P. J., WHITLOCK R. T., MORRIS R. C., ANGERS M., LARAGH J. H. Effect of alpha-methyl DOPA in severe and malignant hypertension. JAMA. 1962 Mar 3;179:673–681. doi: 10.1001/jama.1962.03050090001001. [DOI] [PubMed] [Google Scholar]
  3. DOLLERY C. T., HARINGTON M. Methyldopa in hypertension. Clinical and pharmacological studies. Lancet. 1962 Apr 14;1(7233):759–763. doi: 10.1016/s0140-6736(62)91781-6. [DOI] [PubMed] [Google Scholar]
  4. GILLESPIE L., Jr, OATES J. A., CROUT J. R., SJOERDSMA A. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension. Circulation. 1962 Feb;25:281–291. doi: 10.1161/01.cir.25.2.281. [DOI] [PubMed] [Google Scholar]
  5. HAMILTON M., KOPELMAN H. Treatment of severe hypertension with methyldopa. Br Med J. 1963 Jan 19;1(5324):151–155. doi: 10.1136/bmj.1.5324.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. KINCAID-SMITH P., McMICHAEL J., MURPHY E. A. The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med. 1958 Jan;27(105):117–153. [PubMed] [Google Scholar]
  7. LAWRIE T. D., LORIMER A. R., MCALPINE S. G., REINERT H. CLINICAL TRIAL AND PHARMACOLOGICAL STUDY OF COMPOUND 1029. ("VATENSOL"). Br Med J. 1964 Feb 15;1(5380):402–406. doi: 10.1136/bmj.1.5380.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LEISHMAN A. W. Hypertension: treated and untreated; a study of 400 cases. Br Med J. 1959 May 30;1(5134):1361–1368. doi: 10.1136/bmj.1.5134.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LEISHMAN A. W. Merits of reducing high blood-pressure. Lancet. 1963 Jun 15;1(7294):1284–1288. doi: 10.1016/s0140-6736(63)91983-4. [DOI] [PubMed] [Google Scholar]
  10. ONESTI G., BREST A. N., NOVACK P., MOYER J. H. Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension. Am J Cardiol. 1962 Jun;9:863–867. doi: 10.1016/0002-9149(62)90211-4. [DOI] [PubMed] [Google Scholar]
  11. SCHOTTSTAEDT M. F., SOKOLOW M. The natural history and course of hypertension with papilledema (malignant hypertension). Am Heart J. 1953 Mar;45(3):331–362. doi: 10.1016/0002-8703(53)90147-1. [DOI] [PubMed] [Google Scholar]
  12. SHEPS S. G., SCHIRGER A., OSMUNDSON P. J., FAIRBAIRN J. F., 2nd Methydopa for treatment of hypertension. JAMA. 1963 May 25;184:616–621. doi: 10.1001/jama.1963.03700210050008. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES